Related Experiment Video
Updated: Mar 18, 2026
10:10
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
2.0K
Glucocorticoid therapy and ocular hypertension
1North Texas Eye Research Institute, UNT Health Science Center, Fort Worth, TX, USA.
European Journal of Pharmacology
|July 9, 2016
Summary
Glucocorticoids (GCs) treat eye inflammation but can cause glaucoma. This review explores GC-induced ocular damage and strategies to improve GC therapy for conditions like macular degeneration and diabetic retinopathy.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Age-related macular degeneration, diabetic retinopathy, and uveitis affect millions globally.
- Glucocorticoids (GCs) are used to treat ocular inflammation and edema associated with these conditions.
- Ocular GC therapy can cause severe side effects, including GC-induced ocular hypertension and secondary open-angle glaucoma, a leading cause of blindness.
Purpose of the Study:
- To review the mechanisms of ocular tissue damage induced by glucocorticoids (GCs).
- To discuss the phenomenon of GC-resistance in ocular tissues.
- To explore strategies for enhancing glucocorticoid therapy in ophthalmology.
Main Methods:
- This is a review article, synthesizing existing literature.
- Mechanisms of GC-induced ocular damage are discussed.
- Strategies for improving GC therapy are explored.
Main Results:
- GCs can induce ocular hypertension and secondary open-angle glaucoma.
- GC-resistance can develop, limiting therapeutic efficacy.
- Potential strategies exist to enhance GC therapy and mitigate side effects.
Conclusions:
- GCs are vital for treating ocular inflammation but carry significant risks.
- Understanding GC-induced damage and resistance is crucial for patient safety.
- Further research into enhancing GC therapy is needed to improve outcomes for patients with macular degeneration, diabetic retinopathy, and uveitis.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
01:25Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
01:23Ophthalmic Drug Delivery Systems
173
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
173
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.9K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.9K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
602
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
602